Page All:
Page 1
Nonin Medical Announces the European Launch of EQUANOX Advance(TM) Neonatal/Pediatric Sensor for Regional Oximetry at PGA Conference
MINNEAPOLIS, Dec. 12, 2011 /PRNewswire/ -- Nonin Medical, Inc., the inventor of finger pulse oximeters and a 25-year leader in noninvasive medical monitoring, announced the European launch of an innovative pediatric sensor for use with the company's EQUANOX(TM) Regional Oximetry System. Nonin made the announcement at the 65th Annual Post Graduate Assembly in New York.
The EQUANOX Advance(TM) Model 8004CB Sensor* is the first and only single-sensor solution on the market for patients under 40kg, The 8004CB sensor is designed for use across neonatal and pediatric populations who require accurate oxygen saturation monitoring of cerebral and other tissues in diverse treatment settings. Nonin Medical's complete EQUANOX Advance sensor line, which also includes the Model 8004CA sensor for adults, provides inherent absolute accuracy, reducing the need for complex and time-consuming patient-specific setup.
"Nonin Medical is pleased to release another elegantly simple solution, designed with the clinician in mind, which allows customers to spend more time on care and less time on operating the technology," said Chris Holland, Vice President-Regional Oximetry, Nonin Medical.
<font size="2" face="Arial">Highly portable and versatile, the EQUANOX Model 7600 Regional Oximetry System and the EQUANOX Advance Model 8004CB Neonatal/Pediatric Sensor provide comprehensive four-channel monitoring in cerebral and somatic positions. Nonin Medical's exclusive dual-emitter, spatially resolved sensor design isolates target tissue with consistent repeatability, and four-wavelength optics deliver rSO2 with absolute accuracy. Advanced signal processing ensures stability and responsiveness. The complete EQUANOX system provides key advantages, including:</font>
-- Sensor Optimization for the Patient -- Unique optical spacing to isolate
and target key tissues for neonatal and pediatric populations
-- Portability and Versatility -- Lightweight and durable, with long
battery life, allowing ease of continuous monitoring during patient
transport within the hospital
-- Consistency and Reliability -- Rapid, reliable, response to
physiological change without signal instability and interruptions from
ambient electrical and optical interferences
-- Industry-Leading Accuracy** -- Absolute accuracy that aligns to true
patient physiology, indicating adequacy of perfusion
About Nonin Medical, Inc.
Nonin Medical, Inc. invented finger pulse oximetry and specializes in the design and manufacturing of noninvasive physiological monitoring solutions. Headquartered in Minneapolis, Minn. with an additional distribution and service center in Hudiksvall, Sweden, Nonin Medical distributes its pulse and regional oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries and has more than 100 OEM partners worldwide. For more information, visit http://www.noninequanox.com.
* 510(k) pending** Accuracy data based on 8004CA clinical results
SOURCE Nonin Medical, Inc.
Nonin Medical, Inc.
CONTACT: Melanie Stanek, Director, Corporate Relations of Nonin Medical, Inc., +1-763-577-5514, Melanie.stanek@nonin.com
Web Site: http://www.nonin.com
Nonin Medical Announces the European Launch of EQUANOX Advance(TM) Neonatal/Pediatric Sensor for Regional Oximetry at PGA Conference
MINNEAPOLIS, Dec. 12, 2011 /PRNewswire/ -- Nonin Medical, Inc., the inventor of finger pulse oximeters and a 25-year leader in noninvasive medical monitoring, announced the European launch of an innovative pediatric sensor for use with the company's EQUANOX(TM) Regional Oximetry System. Nonin made the announcement at the 65th Annual Post Graduate Assembly in New York.
The EQUANOX Advance(TM) Model 8004CB Sensor* is the first and only single-sensor solution on the market for patients under 40kg, The 8004CB sensor is designed for use across neonatal and pediatric populations who require accurate oxygen saturation monitoring of cerebral and other tissues in diverse treatment settings. Nonin Medical's complete EQUANOX Advance sensor line, which also includes the Model 8004CA sensor for adults, provides inherent absolute accuracy, reducing the need for complex and time-consuming patient-specific setup.
"Nonin Medical is pleased to release another elegantly simple solution, designed with the clinician in mind, which allows customers to spend more time on care and less time on operating the technology," said Chris Holland, Vice President-Regional Oximetry, Nonin Medical.
<font size="2" face="Arial">Highly portable and versatile, the EQUANOX Model 7600 Regional Oximetry System and the EQUANOX Advance Model 8004CB Neonatal/Pediatric Sensor provide comprehensive four-channel monitoring in cerebral and somatic positions. Nonin Medical's exclusive dual-emitter, spatially resolved sensor design isolates target tissue with consistent repeatability, and four-wavelength optics deliver rSO2 with absolute accuracy. Advanced signal processing ensures stability and responsiveness. The complete EQUANOX system provides key advantages, including:</font>
-- Sensor Optimization for the Patient -- Unique optical spacing to isolate
and target key tissues for neonatal and pediatric populations
-- Portability and Versatility -- Lightweight and durable, with long
battery life, allowing ease of continuous monitoring during patient
transport within the hospital
-- Consistency and Reliability -- Rapid, reliable, response to
physiological change without signal instability and interruptions from
ambient electrical and optical interferences
-- Industry-Leading Accuracy** -- Absolute accuracy that aligns to true
patient physiology, indicating adequacy of perfusion
About Nonin Medical, Inc.
Nonin Medical, Inc. invented finger pulse oximetry and specializes in the design and manufacturing of noninvasive physiological monitoring solutions. Headquartered in Minneapolis, Minn. with an additional distribution and service center in Hudiksvall, Sweden, Nonin Medical distributes its pulse and regional oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries and has more than 100 OEM partners worldwide. For more information, visit http://www.noninequanox.com.
* 510(k) pending** Accuracy data based on 8004CA clinical results
SOURCE Nonin Medical, Inc.
Nonin Medical, Inc.
CONTACT: Melanie Stanek, Director, Corporate Relations of Nonin Medical, Inc., +1-763-577-5514, Melanie.stanek@nonin.com
Web Site: http://www.nonin.com